Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carreno

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Trends in Immunology|October 14, 2003
BTLA: a new inhibitory receptor with a B7-like ligandBeatriz M Carreno, Mary Collins
Science Immunology|November 12, 2017
Heating up cancer vaccinesSaba Ghassemi, Beatriz M Carreno
Annual Review of Immunology|February 28, 2002
The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responsesBeatriz M Carreno, Mary Collins
Scientific American|April 16, 2016
A Vaccine for Cancer?Beatriz M Carreno, Elaine R Mardis
Immunologic Research|August 30, 2003
Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activationLaura L Carter, Beatriz M Carreno
Cancer Research|March 15, 2022
On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next WaveGerald P Linette, Beatriz M Carreno
Current Hematologic Malignancy Reports|June 13, 2019
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor EraGerald P Linette, Beatriz M Carreno
European Journal of Immunology|June 1, 1994
Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surfaceB M Carreno, T H Hansen
Trends in Molecular Medicine|September 5, 2017
Neoantigen Vaccines Pass the Immunogenicity TestGerald P Linette, Beatriz M Carreno
Revista De Neurologia|September 19, 2007
[An observational study of the patterns of carbamazepine and oxcarbazepine utilisation in adult patients with partial epilepsy in Spain]M Rufo-Campos, M Carreno-Martinez
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Trends in Immunology|October 14, 2003
BTLA: a new inhibitory receptor with a B7-like ligandBeatriz M Carreno, Mary Collins
Science Immunology|November 12, 2017
Heating up cancer vaccinesSaba Ghassemi, Beatriz M Carreno
Annual Review of Immunology|February 28, 2002
The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responsesBeatriz M Carreno, Mary Collins
Scientific American|April 16, 2016
A Vaccine for Cancer?Beatriz M Carreno, Elaine R Mardis
Immunologic Research|August 30, 2003
Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activationLaura L Carter, Beatriz M Carreno
Cancer Research|March 15, 2022
On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next WaveGerald P Linette, Beatriz M Carreno
Current Hematologic Malignancy Reports|June 13, 2019
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor EraGerald P Linette, Beatriz M Carreno
European Journal of Immunology|June 1, 1994
Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surfaceB M Carreno, T H Hansen
Trends in Molecular Medicine|September 5, 2017
Neoantigen Vaccines Pass the Immunogenicity TestGerald P Linette, Beatriz M Carreno
Revista De Neurologia|September 19, 2007
[An observational study of the patterns of carbamazepine and oxcarbazepine utilisation in adult patients with partial epilepsy in Spain]M Rufo-Campos, M Carreno-Martinez
Pageof 14